Company Overview and News
Welcome to Seeking Alpha’s Venture Capital Deals of the Week. Follow this account and turn on the e-mail alert to receive VCDeals in your inbox on Saturday mornings.
IBM SPLK NDLS FEYE GOOGL GRUB RPD CSCO MXIM CAKE CMG
Document UNITED STATES
Chicago, IL – August 17, 2018 - Stocks in this week’s article are Celanese Corp. (CE - Free Report) , Maxim Integrated Products, Inc. (MXIM - Free Report) , American Financial Group, Inc. (AFG - Free Report) , Lazard Ltd. (LAZ - Free Report) and Teradyne, Inc. (TER - Free Report) .
HD AFW AFGE AFA AFGH FCCTO BGSF FCCTP FCCO TER AFG LAZ HEAR OXY MXIM FIVE CE FCCT
2018-08-16 globenewswire - 2
SANTA CLARA, Calif., Aug. 16, 2018 (GLOBE NEWSWIRE) -- NVIDIA (NASDAQ: NVDA) today reported revenue for the second quarter ended July 29, 2018, of $3.12 billion, up 40 percent from $2.23 billion a year earlier, and down 3 percent from $3.21 billion in the previous quarter.
HGRL NVDA MXIM
Growth at a reasonable price or GARP is an excellent way for investors to make some quick gains. This strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount. The GARP approach leads to the identification of stocks that are priced below the market or any reasonable target determined by fundamental analysis. These stocks also have solid prospects in terms of cash flow, revenues, earnings per share (EPS) and so on.
HD AFW AFGE AFA AFGH TER AFG CBG LAZ MXIM CBRE CE
Chicago, IL – August 8, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Apple Inc (AAPL - Free Report) , Adobe Systems Incorporated (ADBE - Free Report) , Intel Corporation (INTC - Free Report) , Xilinx, Inc.
XLNX WCG ADBE GS GLSSP SFM AAPL MS INTC MXIM FOX JBK STLD GSC TFG BIG ON GSJ MTH ARW GJS FOXA
Tech shares, which have had a tumultuous start to the month, started scaling north following strong quarterly results from Apple (NASDAQ:AAPL) among others. While computer and software makers are having a ball owing to the White House’s initiative to trim tax rates, high-end gaming, emergence of Internet-of-Things (IoT) and automation are driving demand for chips.
XLNX GS AAPL INTC MXIM ADBE
2018-08-07 zacks - 1
Tech shares, which have had a tumultuous start to the month, started scaling north following strong quarterly results from Apple Inc (AAPL - Free Report) among others. While computer and software makers are having a ball owing to the White House’s initiative to trim tax rates, high-end gaming, emergence of Internet-of-Things (IoT) and automation are driving demand for chips.
XLNX ADBE GS GLSSP AMT AAPL INTC MXIM JBK GSC TFG GSJ GJS GTLS
WallStars show positive broker target price upsides. Top "safer" dividend Technology WallStar, Western Digital, showed 51.55% gains. Top ten averaged 27% per Broker estimates plus dividends. All leaders signaled oversold.
WSO LRCX WDC STX TEL KLAC AMAT AVGO DTST CSCO QCOM INTC MXIM
The company's stock has remained on the same level over the last six months, while the company's fundamentals continue to improve.
Chicago, IL – August 1, 2018 - Stocks in this week’s article Celanese Corp. (CE - Free Report) , Maxim Integrated Products, Inc. (MXIM - Free Report) , American Financial Group, Inc. (AFG - Free Report) , First American Corp. (FAF - Free Report) and Lazard Ltd (LAZ - Free Report) .
AFG AFW LAZ AFGE AFA AFGH MXIM CE
If you’re looking for a profitable portfolio of stocks that will offer the best of value and growth investing, try the growth at a reasonable price or GARP strategy. It helps an investor gain exposure to stocks that are undervalued and have impressive growth prospects.
AFG AFW FDS LAZ AFGE FAF AFA AFGH MXIM CE
If you’re looking for a profitable portfolio of stocks that will offer the best of value and growth investing, try the growth at a reasonable price or GARP strategy. It helps an investor gain exposure to stocks that are undervalued and have impressive growth prospects. Unlike a blend strategy, a portfolio that uses GARP investing is expected to include stocks that offer the best of both value and growth investing.
CWH AFG AFW FDS LAZ GPN AFGE AFA AFGH MXIM CE
Maxim Integrated Products, Inc. (MXIM - Free Report) reported fourth-quarter fiscal 2018 adjusted earnings of 73 cents per share, surpassing the Zacks Consensus Estimate by 3 cents. Also, earnings increased 16% from the year-ago quarter but were flat sequentially.
GRPN ALGN ADI SAH MXIM
2018-07-27 seekingalpha - 4
Prescience Point’s analysis indicates that the 43.7% or 804 bps expansion in ENPH’s gross margin over the past three quarters is almost entirely attributable to potentially improper accounting.
39IB LGEPF TXN SPWR ENPH VSLR LGEAF CGIP CGI SEDG LGLD FSLR MXIM LGEJY LGEIY TSL
12h - Asif
Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...
13h - Asif
Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...
13h - Asif
General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...
as of ET